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Abstract
Background: Ever since its discovery the mycobacterial proline-proline-glutamic acid (PPE) family of proteins has generated
a huge amount of interest. Understanding the role of these proteins in the pathogenesis of Mycobacterium tuberculosis
(Mtb) is important. We have demonstrated earlier that the PPE18 protein of Mtb induces IL-10 production in macrophages
with subsequent downregulation of pro-inflammatory cytokines like IL-12 and TNF-a and favors a T-helper (Th) 2-type of
immune response.
Methodology/Principal Findings: Using a ppe18 genetic knock-out Mtb strain, we have now carried out infection studies in
mice to understand the role of PPE18 in Mtb virulence. The studies reveal that lack of PPE18 leads to attenuation of Mtb
in vivo. Mice infected with the ppe18 deleted strain have reduced infection burden in lung, liver and spleen and have better
survival rates compared to mice infected with the wild-type Mtb strain.
Conclusions/Significance: Taken together our data suggest that PPE18 could be a crucial virulence factor for intracellular
survival of Mtb.
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Introduction
Tuberculosis (TB), both pulmonary and extrapulmonary, is a
major global health concern. According to the World Health
Organization, 1.3 million people died of tuberculosis in 2008 and
34% of the victims were from South-East Asia. Also, one third of
the world population is infected with Mtb asymptomatically. TB
also accounts for 32% of deaths among AIDS afflicted individuals
[1]. Mtb is a highly successful pathogen. It has developed several
efficient strategies to survive and replicate in the macrophage, its
primary host cell [2]. These strategies include prevention of fusion
of phagosome and lysosome, deterrence of phagosome acidifica-
tion, expression of virulence proteins, protection from reactive
oxygen species (ROS), inhibition of protective cytokines like
interleukin (IL)-12, tumor necrosis factor (TNF)-a, evasion of
antigen presentation [3–6] and inhibition of apoptosis [7]. Mtb
turns down the T helper (Th) 1-type immune response which is
beneficial to the host and up-regulates Th2-type cytokines which
are anti-inflammatory and helpful for its survival [8]. The bacilli
with the help of these mechanisms live inside a human host,
sometimes for years together. Some of these mechanisms are well
understood while others remain to be comprehended. Under-
standing the host-pathogen interactions during Mtb infection will
help immensely in combating the menace of tuberculosis
worldwide.
The acid rich proline-glutamic acid (PE)/PPE family of proteins
is exclusive to mycobacteria. Unraveling of the Mtb genome
revealed that 10% of its coding ability is devoted to the PE and
PPE families, comprising of 99 and 68 members respectively
[9,10]. There is a gradual expansion of PE/PPE proteins from
non-pathogenic to pathogenic mycobacteria [11]. PE and PPE
family members are characterized by the presence of conserved
proline-glutamic acid or proline-proline-glutamic acid motifs of
110 and 180 amino acids respectively at the N-terminal region
[9,12]. The C-terminal region is found to be highly variable [13].
Depending upon the presence of characteristic repeats, the PE and
PPE families can be divided into subfamilies [11]. The PE_PGRS
and PPE_MPTR subfamilies have long stretches of GC rich
repeats which are believed to be the hotspots for recombination
events and other mutations. This leads to a great deal of sequence
variation and polymorphism in these proteins [14]. There is also
speculation that this high variability may contribute to the
antigenic variation that helps the pathogen to evade host
protective immune responses [15]. Not much information is
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e52601
available about the exact patho-physiological role of PE/PPE
proteins. However, there is evidence to suggest that they are up-
regulated during stress conditions and may hence facilitate
bacterial survival during infection [16,17]. Also, it has been found
that PE/PPE proteins modulate macrophage protective functions,
cytokine secretion, apoptosis and necrosis of host cells [16,18–20].
PPE18 (Rv1196), also known as Mtb39a, a member of the PPE
family, is expressed more in Mtb as compared to Mycobacterium
bovis [21]. Previous work by us documents that PPE18 binds to the
toll like receptor (TLR) 2 on macrophages, and via activation of
the p38 mitogen activated protein kinase (MAPK) pathway, it up-
regulates IL-10 cytokine production. Also, its interaction with
TLR2 leads to phosphorylation of the suppressor of cytokine
signaling (SOCS) 3 protein which then physically interacts with
the IkBa-nuclear factor (NF)-kB/c-rel complex. This interaction
prevents the nuclear translocation of p50 and p65 NF-kB and c-rel
transcription factors. As a consequence, there is a downregulation
of transcription of NF-kB-regulated genes like IL-12 and TNF-a.
Thus, PPE18 was found to selectively downregulate the proin-
flammatory and Th1-type immune response [5,22]. At the same
time, it increases secretion of IL-10 [22] which favors a Th2-type
response. Also, our previous work reveals that macrophages
infected with Mtb strain lacking PPE18 produce less IL-10 and
more IL-12 p40 compared to those infected with wild-type Mtb
strain. Interestingly, PPE18 was shown to skew the anti-PPD Th1
response towards the Th2-type in T cells isolated from PBMCs
from BCG vaccinated individuals [22]. To understand the role of
PPE18 in Mtb virulence in vivo, in the present study, the ppe18
knock-out (KO) strain was used in a murine model of Mtb
infection. Our studies revealed that mice infected with ppe18 KO
bacteria had lower bacterial load, less tissue pathology and
improved survival rates compared to mice infected with wild-type
(WT) bacteria. These data reveal that PPE18 probably plays an
important role in the survival and multiplication of Mtb bacilli
during infection.
Materials and Methods
Bacterial Strains
The Mtb ppe18 knock-out (KO) strain (ppe18 null mutant;
mutant ID 1440, MT1234) and its corresponding wild-type (WT)
strain (CDC1551) were obtained from Colorado State University
(as part of National Institutes of Health National Institutes of
Health NIAID Contract No. HHSN266200400091C entitled,
‘‘Tuberculosis Vaccine Testing and Research Materials’’). The M.
tuberculosis strains were grown in Difco Middlebrook 7H9 broth
(BD Biosciences, Sparks, MD, USA) supplemented with 0.2%
glycerol (Sigma-Aldrich, St. Louis, MO), 0.5% Tween 80 (Sigma-
Aldrich), and 10% oleic acid albumin dextrose complex (OADC,
BD Biosciences) in a biosafety level 3 (BSL-3) facility at
International Centre for Genetic Engineering and Biotechnology
(ICGEB), New Delhi, India.
Mouse Infections
Four to six weeks old C57Bl/6 mice of either sex were kept in
individually ventilated cages in a BSL-3 animal house at ICGEB,
New Delhi. Animal experiments were conducted at the animal
house facility of ICGEB, New Delhi, India according to the
guidelines of the Institutional Animal Ethics Committee. Mice
were infected with 16108 of WT or ppe18 KO Mtb strain by
aerosol route using the Madison Aerosol Chamber (University of
Wisconsin, Madison, WI) pre-calibrated to deliver small inocula of
bacilli (delivering about 80–130 bacilli of both the strains per lung
of animal sacrificed at day one as assessed by killing two mice 24
hours after exposure to aerosol and plating the lungs homogenates
on nutrient 7H11 agar and counting CFU after a 21 days
incubation at 37uC).
Infection Burden in Organs
Bacterial loads in lung, liver, and spleen were evaluated at
different time points after aerosol infection with WT or ppe18 KO
Mtb to follow the course of infection. For this, lung, liver and
spleen were aseptically removed from euthanized animals from
each group. Organs were homogenized in sterile saline containing
0.05% Tween 80 (Sigma-Aldrich). Serial dilutions of homogenized
organs were plated on 7H11 plates supplemented with 10%
OADC (BD Biosciences). Plates were incubated at 37uC and
colonies were counted after 21 days.
Histopathology
Lung, liver and spleen of mice infected by aerosol route with
either WT or ppe18 KO Mtb strain were aseptically removed from
euthanized animals and were fixed in 10% formalin and then
embedded in paraffin wax. Sections were then stained with
hematoxylin and eosin (H&E) stain for visualizing mammalian
cells. Sections were visualized under an Olympus CX21 micro-
scope (Olympus, Japan). Also, microphotographs were taken using
an Olympus DP72 CCD camera attached to the microscope.
DP2-BSW software was used for image analysis.
Statistical Analysis
Data analysis was performed using the Student’s t test,
considering P values ,0.05 to be significant. Values are presented
as mean bacterial count 6 standard error of the mean (SEM) of 5
animals per group per time point [23,24].
Results
PPE18 Confers a Growth Advantage to Mtb in vivo in a
Mouse Model of Infection
To assess the role of PPE18 in growth of Mtb in vivo, C57Bl/6
mice were infected with either WT or ppe18 KO strains of Mtb via
the aerosol route and the bacterial burden was estimated in lung,
liver and spleen of infected animals at 3 different time points (3
weeks, 6 weeks and 9 weeks) after infection. The aerosol infection
deposited 80–130 colony forming units (CFUs) per lung (as
assessed by counting CFUs in two infected mice per Mtb strain at
day 1 post infection) Infection through aerosol deposits Mtb
directly into the lungs and hence considered to be closest to
physiological mode of infection. Lungs being the primary site of
infection showed maximum CFUs at all the time points examined
(Figure 1). In mouse model upon infection, bacteria are known to
disseminate from lungs to liver and spleen [25]. It has been shown
that in mice infected with a low dose of Mtb by aerosol route,
bacterial numbers increase steadily with time to reach a peak at
about 3 weeks and thereafter may decrease considerably [26,27]
when the host cell-mediated immune responses are high [25,28–
30]. Similarly, we also observed a steady rise in the bacterial load
in all the organs till 3 weeks after aerosol infection and then a
decrease at 6 weeks and 9 weeks post infection. Interestingly, we
found that the number of ppe18 KO bacteria remained signifi-
cantly less in all the organs at almost all the time points
investigated (Figure 1). In the lungs of ppe18 KO-infected mice,
the mean bacterial counts (6 SEM) were significantly lower at 3
weeks post infection as compared to those of infected with WT
Mtb strain and this trend continued to later time points also (6
weeks and 9 weeks) (Figure 1A). Similar observations were made in
liver (Figure 1B) as well as in spleen (Figure 1C). These data
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indicate that the ppe18 KO strain probably failed to multiply as
robustly as the wild-type strain during the acute phase of infection
in vivo. PPE18 has previously been reported to be non-essential for
bacterial growth in vitro [31]. Our results indicate that PPE18
probably plays a role in replication and survival of Mtb in vivo and
therefore, may be a candidate virulent factor.
Mice Infected with ppe18 KO Strain Show a Reduced
Degree of Inflammation and Tissue Damage as
Compared to mice Infected with WT Mtb Strain
Aerosol infection deposits Mtb directly in the lungs where their
numbers slowly increase reaching a peak at about 3 weeks post
infection. This is also the time when the influx of immune cells into
the lungs is very high [28–30]. From the lungs the infection
disseminates to liver and spleen. It has been reported that upon
initiation of infection, bacteria in the lungs are lodged in the
alveolar macrophages, myeloid dendritic cells (DCs) and neutro-
phils which form the first line of defense [25]. T cells first get
activated in the draining lymph node and then migrate to the
lungs about 14–21 days post infection [32]. In mice, the immune
cells (macrophages and lymphocytes) are not arranged in the form
of well defined granulomas that are observed in humans. It has
also been observed that the immune response in the mouse model
is often exaggerated and contributes to the aggravated tissue
pathology resulting in death of the host even though the bacterial
numbers are not significantly high [25]. Therefore, we examined
the tissue damage in lung, liver and spleen in mice infected with
WT and ppe18 KO Mtb strains in vivo by histopathological
analyses. The extent of inflammation and tissue damage due to
infection as seen in the hematoxylin and eosin (H&E) stained
sections of lung and liver from mice infected with WT Mtb was
found to be markedly pronounced (Figures 2 and 3, left panel)
than that observed in mice infected with the ppe18 KO Mtb
(Figures 2 and 3, right panel). The lungs of animals infected with
WT or ppe18 KO strains of Mtb became infiltrated with
lymphocytes and macrophages at later time points after aerosol
infection. However, the infiltration and lesions were more severe
in mice infected with WT Mtb. Mice infected with ppe18 KO had
more intact alveolar spaces while mice infected with WT Mtb
almost had none, especially at 21 and 60 weeks post infection
(Figure 2). The lesions and tissue damage observed in the WT
Mtb-infected animals were graded 4 (marked with 51–75% tissue
affected) and 5 (severe with 76–100% tissue affected) and that in
the ppe18 KO-infected animals were graded 3 (moderate with 26–
50% tissue affected), 60 weeks post infection (Figure 2). A similar
trend was observed in the liver. The lesions observed in liver were,
Figure 1. Infection burden in mice infected with wild-type (WT) or ppe18 knock-out (KO) Mtb strain. C57BL/6 mice were infected
aerogenically with a low dose (16108) of either WT or ppe18 KO strains of Mtb. At different time points post infection, mice were sacrificed and CFU
counts were measured in lung (A), liver (B) and spleen (C). Data are mean 6 SEM of results for five mice per group for each time point.
doi:10.1371/journal.pone.0052601.g001
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however, less severe compared to those in the lungs. Small foci of
lymphocytic infiltration began to appear 3 weeks post infection in
WT-infected mice (Figure 3). The foci were better observed at a
magnification of 100X (Figure S1). The lesions became more
numerous by 60 weeks post infection (Figure 3). Liver sections
from ppe18 KO-infected mice seemed normal at 3 and 21 weeks
post infection and this correlated well with low CFU counts in the
liver (Figure 1B), mild lymphocytic infiltration was observed in
livers of ppe18 KO-infected mice only at 60 weeks post infection
(Figure 3). Effect of infection was not observed in spleen of both
WT- and ppe18 KO Mtb infected mice sacrificed at 3 weeks.
Histiocytosis or accumulation of macrophages in spleen was
observed at 21 and 60 weeks post infection in mice infected with
WT Mtb strain (Figure 4), however, the spleen tissue structure of
ppe18 KO strain-infected mice appeared to be normal (Figure 4).
Our observations from the histological slides indicated that in
comparison to the WT, the ppe18 KO strain elicited a reduced and
delayed inflammatory response in lung, liver and spleen of the
infected mice.
Infection with ppe18 KO Strain of Mtb Exhibits Reduced
Tuberculosis Induced Fatality
To reckon the total effect of in vivo growth and inflammation,
survival of mice infected with WT and ppe18 KO strains of Mtb
was monitored over a prolonged period of time. No deaths were
registered in the group of mice infected with the ppe18 KO strain
during the entire study period of 60 weeks. However, in the group
of mice infected with the WT Mtb, survival rate had dropped to
25% 60 weeks post infection (Figure 5). Also, mice infected with
ppe18 KO strain visibly appeared healthier. The percentage
increase in the weight of mice infected with ppe18 KO strain 9
weeks after infection was 5562% compared to the 31.965%
increase in the weight of mice infected with the WT strain (Figure
S2).
Discussion
The virulence of Mtb is complicated and multifaceted. Earlier
in vitro studies by us had indicated that PPE18 might aid in
virulence of Mtb by favoring the non-protective anti-inflammatory
Th2-type response and downregulating the protective pro-
inflammatory and/or Th1-type immune response [5,22]. The
present infection studies in a mouse model have indeed revealed
that deletion of PPE18 reduces the capacity of Mtb to multiply
in vivo. Both in vitro [5,22] and in vivo studies thus point to the fact
that PPE18 probably plays an important role in the virulence of
Mtb.
It is documented that immunity to Mtb in host depends on
robust Th1-type T cell response while Th2-type response leads to
enhanced susceptibility to mycobacterial infection [33]. Among
the several factors that regulate T cell polarization and Th1/Th2
development, the cytokines produced by the activated macro-
phages have the most influential role [34,35]. IL-12 [36–39] and
TNF-a [40,41] cytokines are known to trigger the anti-mycobac-
terial protective Th1-type immune response [38,42,43]. In
contrast, IL-10 cytokine not only perturbs the Th1 response but
also polarizes the T-cell immune response towards the non-
protective Th2-type and promotes Mtb survival inside the host
[44–48]. IL-10 has been shown to be linked with the ability of Mtb
to evade immune responses and mediate long-term infections in
the lungs [49]. Thus, mycobacterial strategy at every step is likely
to perturb the macrophage IL-12/IL-10 balance to subsequently
establish a Th2-type response. This hypothesis is supported by the
observation that pathogenic Mtb bacteria have evolved mecha-
nisms to suppress IL-12 and TNF-a production [50–53]. On the
other hand, virulent clinical strains of Mtb are found to be
proficient at stimulating high levels of IL-10 and inducing
immunosuppression in the host [54,55]. Interestingly, IL-10
transgenic mice re-activate latent tuberculosis infection and
overproduction of IL-10 causes increase in susceptibility to
mycobacterial infection [56]. Also, in patients with active TB
infection, the anti-PPD Th1 T cell responses are found to be
downregulated [57,58]. All these findings indicate an important
role of the IL-12/TNF-a and IL-10 balance in the regulation of
Mtb infection and disease progression; however, the mechanisms
by which the bacilli influence these signaling pathways to favor
their long-term survival and persistence inside the host are not well
understood.
Previous work by us reveals that PPE18 is a TLR2 ligand and its
binding to TLR2 results in activation of p38 MAPK, which leads
to secretion of higher levels of IL-10 [22]. At the same time, this
interaction also inhibits LPS-mediated IL-12 p40 and TNF-a
induction involving the p38 MAPK-SOCS3-NF-kB/c-rel signal-
ing pathway [5]. Thus, it appears that PPE18 probably plays a key
role in regulating the Th1/Th2 cytokine balance, which in turn
can influence bacterial persistence and multiplication inside the
host [59,60]. We have also documented earlier that the anti-PPD
T cell response is skewed towards the Th2-type by PPE18 in T
cells isolated from PBMCs from the BCG-vaccinated individuals,
and an important role of IL-10 in the downregulation of anti-PPD
Th1 response by PPE18 [22]. Thus, how much of the PPE18-
induced modulation of the immune response could directly
contribute to Mtb virulence in vivo seemed an interesting and
logical issue to be looked at. In the present study, we observed that
absence of ppe18 in Mtb resulted in a marked decrease of virulence
with low bacterial counts and reduced pathology in the lung, liver
and spleen when compared with the WT strain in a murine model.
Also we observed absence of mortality in mice infected with ppe18
KO strain compared to mice infected with CDC1551 wild-type
strain. Thus we predict that deletion of ppe18 impairs the ability of
the bacilli to induce a favorable anti-inflammatory immune
environment. Although the precise mechanism of the reduced
virulence of ppe18 knock-out strain is unclear, this could be due to
the fact that in the absence of PPE18, probably a better protective
immune response (especially Th1) is generated which augurs well
for the host [61–63]. It is also possible that PPE18 targets other
immune effecter molecules that lie downstream of the SOCS3-NF-
kB signaling cascade that has previously been shown to be affected
by binding of PPE18 to TLR2 [5] to downregulate anti-
mycobacterial protective immune responses. The exact reason
for low numbers of ppe18 knock-out Mtb strain in vivo needs to be
further investigated.
The aerosol model of Mtb infection in mice fails to give rise to
the classical granulomas in the lungs that are typically observed in
people suffering from tuberculosis. The infected mice usually show
loose aggregates of macrophages and lymphocytes that infiltrate
into the lungs upon infection [64]. Such aggregates were also
observed in our studies. These clusters of immune cells were seen
to appear earlier in the lungs of mice infected with the WT Mtb
strain. On the other hand, we observed fewer CFUs in mice
infected with the ppe18 KO Mtb strain, that resulted in delayed
onset of lung, liver and spleen pathology as compared to the WT
Mtb strain. This is well reflected in the absence of mortality in
mice infected with ppe18 KO strain whereas mice infected with
WT Mtb strain failed to survive beyond 60 weeks. Within the
localized environment of the granulomas, the immune cells
regulate bacterial multiplication and thus control the spread of
infection within the lungs and to other organs [65]. Various studies
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have indicated that even though the bacterial replication slows
down after 3–4 weeks of infection, the infected mice might
eventually die as a result of organ damage caused by the bacteria
[29,66]. We observed that the number of WT bacteria after
aerosol infection increased at 3 weeks from day 1 and then
decreased when examined at 6 weeks and 9 weeks time point.
However, in these mice, we observed exacerbated lung as well as
liver and spleen pathology at later time points (21 weeks and 60
weeks) which was associated with increased mortality. The
decrease in CFU counts in WT-infected mice at later time points
Figure 2. Histopathology of lungs frommice infected with wild-type (WT) or ppe18 knock-out (KO) Mtb strain. Lung sections from mice
following infection with either WT (left panel) or ppe18 KO (right panel) strains of Mtb were stained with hematoxylin and eosin (H&E) stain at
different time points post infection. Photographs of representative sections from 2 mice visualized at 40X magnification are shown.
doi:10.1371/journal.pone.0052601.g002
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like 6 weeks and 9 weeks compared to 3 weeks time point post
infection as observed in our study could be due to induction of an
effective immune response, thereby keeping the intracellular
bacterial load down. However, at all the time points studied,
tissue pathology was found to be much less severe in mice infected
with ppe18 KO strain explaining the absence of mortality in these
animals.
Mycobacterial virulence factors are defined as the traits that
cause disease progression in host. The CFU load, histopathology
and survival of the host after bacterial infection determine the
degree of virulence. The growth of Mtb inside a host is an
important indicator of virulence. Thus, observed low CFU counts
of ppe18 KO Mtb strain in mice and longer survival of the mice
infected with ppe18 KO strain could possibly mean that PPE18 is a
virulence factor of Mtb. Correlations between reduced pathology
accompanied by improved survival of the host have been made
earlier in studies using Mtb strains deficient in mce operons [67]
and the serine/threonine kinase PknG [68]. In both these studies,
multiplication of the knock-out strains was found to be compro-
mised in vivo. Similarly, mice infected with DsigC mutant had CFU
counts in the lung homogenates one log unit lower than the wild-
type CDC1551 and DsigC complemented mutant groups at day
28 and this observation persisted up to day 120 [69]. DsigC
mutant-infected mice show milder lung pathology and remained
healthy and alive for an extended time in comparison to the
CDC1551 and DsigC complemented mutant groups [69].
Interestingly, DsigC mutant strain also proliferated poorly in
guinea pig models [69]. Similar results were also observed when
guinea pigs and mice were infected with Mtb DdosR mutant strain
[70] or with Mtb strain harboring several sigma factor mutants
Figure 3. Histopathology of livers frommice infected with wild-type (WT) or ppe18 knock-out (KO) Mtb strain. Liver sections from mice
infected with either WT (left panel) or ppe18 KO (right panel) strains of Mtb were stained with hematoxylin and eosin (H&E) at different time points
post infection. Photographs of representative sections from 2 mice visualized at 40X magnification are shown. Arrows indicate the sites of
lymphocytic infiltration.
doi:10.1371/journal.pone.0052601.g003
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[71]. All these observations indicate that poorer bacterial growth
and reduced lung pathology in animal models can contribute to
prolonged host survival upon infection with mutant Mtb strains
[27,67–75].
The PPE family comprises of 69 acid-rich members. PPE
proteins such as PPE44 (Rv2770c), Rv2608, Rv1168c, Rv2430c
etc have been found to elicit potent B and T cell responses [76–
79]. Interestingly, Rv0485, the transcriptional regulator of the
pe13/ppe18 pair has been shown to be a virulence factor in a
murine model of Mtb infection [17]. Our studies, however, focus
directly on the role of PPE18 in Mtb virulence. This study specially
gains relevance because PPE18 is a component of Mtb72f, a Mtb
subunit vaccine which is currently in clinical trials [80]. Therefore,
it becomes imperative to study and understand the function of
PPE18 in Mtb virulence. PPE18 is thought to be present on the
bacterial surface [22,81]. Results presented in this study highlight
the important role of PPE18 in replication and survival of Mtb
in vivo. Absence of PPE18 perhaps slows down the rate of bacterial
replication in vivo. Therefore, antibodies and other therapeutic
strategies that target the PPE18 protein might help in controlling
Mtb infection in a better way.
Figure 4. Histopathology of spleens from mice infected with wild-type (WT) or ppe18 knock-out (KO) Mtb strain. Spleen sections from
mice infected with either WT (left panel) or ppe18 KO (right panel) strains of Mtb were stained with hematoxylin and eosin (H&E) at different time
points post infection. Photographs of representative sections visualized at 200X magnification are shown. Arrows indicate the sites of macrophage
infiltration.
doi:10.1371/journal.pone.0052601.g004
Figure 5. Survival of mice infected with wild-type (WT) or ppe18
knock-out (KO) Mtb strain. Survival of C57BL/6 mice following a
low-dose aerosol infection with either WT or ppe18 KO strains of Mtb
was monitored for 420 days post infection. The starting number of mice
in each group was 8.
doi:10.1371/journal.pone.0052601.g005
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Supporting Information
Figure S1 Histopathology of liver of mice infected with either
wild-type (WT) or ppe18 KO M. tuberculosis strain at higher
magnification. H&E-stained liver sections from WT (left panel)
and ppe18 KO (right panel) strain infected mice were observed at
100X magnification. Arrows indicate the sites of lymphocytic
infiltration.
(TIF)
Figure S2 Effect of M. tuberculosis wild-type (WT) or ppe18
KO infection on weight of mice. Weight of mice was taken 9 weeks
after they were infected with either WT or ppe18 KO strains of M.
tuberculosis. The percentage increase in weight was calculated
with respect to the average weight of 4–6 weeks old uninfected
mice. Data shown is mean 6 SEM for a total of 12 mice.
(TIF)
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